Formulation and Development of In Situ Nasal Gelling Systems for Quetiapine Fumarate-Loaded Mucoadhesive Microemulsion

Journal of Pharmaceutical Innovation

Volumn 10, Issue 4, 2015, Pages 357-373

  Patel, Nirav ^a   Baldaniya, Manoj ^a   Raval, Mihir ^a   Sheth, Navin ^a  

^a SAURASHTRA UNIVERSITY   (India)

Author keywords

In vivo pharmacokinetic study; Intranasal delivery; Mucoadhesive microemulsion; Nasal ciliotoxicity; Peceol; Quetiapine fumarate; Transcutol P

Indexed keywords

CHITOSAN; DIETHYLENE GLYCOL MONOETHYL ETHER; POLOXAMER; POLYSORBATE 20; QUETIAPINE; WATER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; IN SITU NASAL GELLING SYSTEM; MALE; MICROEMULSION; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; TITRIMETRY; ZETA POTENTIAL;

EID: 84947867280     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-015-9232-7     Document Type: Article

References (48)

1. Miller C. The evolution of schizophrenia: a model for selection by infection, with a focus on NAD. Curr Pharm Design. 2009;15:100–09.
2. Nasrallah H, Targum S, Tandon R, McCombs J, Ross R. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatr Serv. 2005;56:273–82.
3. Nordon C, Rouillon F, Barry C, Gasquet I, Falissard B. Determinants of treatment satisfaction of schizophrenia patients: results from the ESPASS study. Schizophr Res. 2012;139:211–17.
4. Factor S. Pharmacology of atypical antipsychotics. Clin Neuropharmacol. 2002;25:153–57.
5. Casey P, Robison K, Castaer J. Quetiapine fumarate. Drug Future. 1996;21:483–89.
6. Goldstein J. Quetiapine fumarate (Seroquel(R)): a new atypical antipsychotic. Drugs Today. 1999;35:193–98.
7. Narala A, Veerabrahma K. Preparation, Characterization and evaluation of quetiapine fumarate solid lipid nanoparticles to improve the oral bioavailability. J Pharmaceutics. 2013:1-7.
8. Chien Y, Su K, Chang S. Nasal systemic drug delivery. New York: M. Dekker; 1989.
9. Sakane T, Yamashita S, Yata N, Sezaki H. Transnasal delivery of 5-fluorouracil to the brain in the rat. J Drug Target. 1999;7:233–40.
10. Li L, Nandi I, Kim K. Development of an ethyl laurate-based microemulsion for rapid-onset intranasal delivery of diazepam. Int J Pharm. 2002;237:77–85.
11. Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today. 2002;7:1184–89.
12. Graff C, Pollack G. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci. 2005;94:1187–95.
13. Ugwoke M, Verbeke N, Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol. 2001;53:3–22.
14. Lawrence M, Rees G. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliver Rev. 2012;64:175–93.
15. Porecha S, Shah T, Jogani V, Naik S, Misra A. Microemulsion based intranasal delivery system for treatment of insomnia. Drug Deliv. 2009;16:128–34.
16. Jansson B, Hagerstrom H, Fransen N, Edsman K, Bjork E. The influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivo. Eur J Pharm Biopharm. 2005;59:557–64.
17. Cao S, Ren X, Zhang Q, Chen E, Xu F, Chen J, et al. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm. 2009;365:109–15.
18. Madan M, Bajaj A, Lewis S, Udupa N, Baig J. In situ forming polymeric drug delivery systems. Indian J Pharm Sci. 2009;71:242–48.
19. Chaturvedi M, Kumar M, Pathak K. A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharma Tech Res. 2011;2:215–22.
20. Gao Z, Choi H, Shin H, Park K, Lim S, Hwang K, et al. Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. Int J Pharm. 1998;161:75–86.
21. Cho H, Ku W, Termsarasab U, Yoon I, Chung C, Moon H, et al. Development of udenafil-loaded microemulsions for intranasal delivery: in vitro and in vivo evaluations. Int J Pharm. 2012;423:153–60.
22. Vessalli E, Edjlali L, Rezaei M, Hokmabadi F. HPLC and spectrophotometric determination and formulation of quetiapine fumarate in the pharmaceutical dosage forms. Asian J Chem. 2013;25:4141–44.
23. Worachun N, Opanasopit P, Rojanarata T, Ngawhirunpat T. Development of ketoprofen microemulsion for transdermal drug delivery. Adv Mat Res. 2012;506:441–44.
24. Chandra A, Sharma P, Irchhiaya R. Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone. Asian J Pharm. 2009;3:30–8.
25. Garti N, Clement V, Fanun M, Leser M. Some characteristics of sugar ester nonionic microemulsions in view of possible food applications. J Agr Food Chem. 2000;48:3945–56.
26. Hathout R, Woodman T, Mansour S, Mortada N, Geneidi A, Guy R. Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci. 2010;40:188–96.
27. Pathak R, Prasad Dash R, Misra M, Nivsarkar M. Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route. Acta Pharm Sinica B. 2014;4:151–60.
28. Vyas T, Babbar A, Sharma R, Singh S, Misra A. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting. J Pharm Sci. 2006;95:570–80.
29. Dhawan S, Singla A, Sinha V. Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods. AAPS PharmSciTech. 2004;5:122–28.
30. Jogani V, Shah P, Mishra P, Mishra A, Misra A. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting. Alz Dis Assoc Dis. 2008;22:116–24.
31. Mandrioli R, Fanali S, Ferranti A, Raggi M. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. J Pharmaceut Biomed. 2002;30:969–77.
32. Patel N, Chotai N, Patel J, Soni T, Desai J, Patel R. Comparison of in vitro dissolution profiles of oxcarbazepine-HP β-CD tablet formulations with marketed oxcarbazepine tablets. Dissolut Technol. 2008;15:28–34.
33. Montenegro L, Carbone C, Condorelli G, Drago R, Puglisi G. Effect of oil phase lipophilicity on in vitro drug release from o/w microemulsions with low surfactant content. Drug Dev Ind Pharm. 2006;32:539–48.
34. Mouri A, Diat O, El Ghzaoui A, Bauer C, Maurel J, Devoisselle J, et al. Phase behavior of reverse microemulsions based on Peceol®. J Colloid Interf Sci. 2014;416:139–46.
35. Kawakami K, Yoshikawa T, Moroto Y, Kanaoka E, Takahashi K, Nishihara Y, et al. Microemulsion formulation for enhanced absorption of poorly soluble drugs. J Control Release. 2002;81:65–74.
36. El-Hadidy G, Ibrahim H, Mohamed M, El-Milligi M. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation. Drug Dev Ind Pharm. 2012;38:64–72.
37. Patel R, Patel M, Bhatt K, Patel B. Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine. Bull Pharm Sci. 2013;51:243–53.
38. 2. J Euro Ceramic Soc. 2012;32(1):235–44.
39. Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda A. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicles skin interaction. J Control Release. 2005;103:123–36.
40. Basu S, Bandyopadhyay A. Characterization of mucoadhesive nasal gels containing midazolam hydrochloride prepared from Linum usitatissimum L. mucilage. Brazilian J Pharm Sci. 2011;47:817–23.
41. Cao S, Zhang Q, Jiang X. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy. Acta Pharmacol Sin. 2007;28:584–90.
42. Patel A, Vavia P. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007;9:E344–52.
43. Cai Z, Song X, Sun F, Yang Z, Hou S, Liu Z. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin. AAPS PharmSciTech. 2011;12:1102–09.
44. Patel M, Patel R, Parikh J, Solanki A, Patel B. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. AAPS PharmSciTech. 2009;10:917–23.
45. Ryoo H, Park C, Chi S, Park E. Development of propofol-loaded microemulsion systems for parenteral delivery. Arch Pharm Res. 2005;28:1400–04.
46. Serajuddin A. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–66.
47. Piao H, Balakrishnan P, Cho H, Kim H, Kim Y, Chung S, et al. Preparation and evaluation of fexofenadine microemulsions for intranasal delivery. Int J Pharm. 2010;395:309–16.
48. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech. 2007;8:191–99.